
Boehringer Ingelheim is investing €85 million in manufacturing capacity for its Respimat Soft Mist Inhaler in the face of growing …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

